Tartrate and malate salts of trans1-((1R,3S)-6-chloro-3-phenylindan-1-yl) -3,3-dimethylpiperazine

Details for Australian Patent Application No. 2006215956 (hide)

Owner H. Lundbeck A/S

Inventors Lopez De Diego, Heidi; Nielsen, Ole; Bang-Andersen, Benny

Agent Watermark

Pub. Number AU-A-2006215956

PCT Pub. Number WO2006/086985

Priority PA200500238 16.02.05 DK; 60/653,418 16.02.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

International Classifications

C07D 295/073 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086985 Priority application(s): WO2006/086985

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215957-Crystalline base of trans1-((1R,3S)-6-chloro-3-phenylindan-1-yl) -3,3-dimethylpiperazine

2006215955-Process for making trans-1-((1R, 3S)-6-chloro-3-phenylindan-1-yl)-3, 3-dimethylpiperazine